Mas Malagarriga N., Ruiz Ramos J., Juanes Borrego A.M., Agra Montava I., Vega Hanna L., López Vinardell L., Puig Campmany M., Mangues Bafalluy M.A.. Risk factors associated with emergency service re-visits in frailty diabetic patients who consult for hypoglycaemia. Medicina De Familia-Semergen. 2022; 48(3)DOI:10.1016/j.semerg.2021.09.011. PMID:34848135. IF:(Q/D).

Iznardo, H, Bredrup, C, Bernal, S, Gladkauskas, T, Mascaro, JM, Roe, E, Baselga, E. Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome. AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2022; 188(4)DOI:10.1002/ajmg.a.62603. PMID:34894066. IF:2.000(Q3/8D).

Blauvelt, A, Tsai, TF, Langley, RG, Miller, M, Shen, YK, You, Y, Yang, YW, Papp, KA, Puig, L. Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2022; 86(4)DOI:10.1016/j.jaad.2021.11.004. PMID:34798201. IF:13.800(Q1/1D).

Fernandez-Simon, E, Suarez-Calvet, X, Carrasco-Rozas, A, Pinol-Jurado, P, Lopez-Fernandez, S, Pons, G, Serra, JJB, de la Torre, C, De Luna, N, Gallardo, E, Diaz-Manera, J. RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy. Journal of Cachexia Sarcopenia and Muscle. 2022; 13(2)DOI:10.1002/jcsm.12923. PMID:35132805. IF:8.900(Q1/1D).